Celesta Capital
VC Fund
San Francisco, United States
Celesta Capital is a venture capital firm that invests in entrepreneurs and disruptive technology companies. Their management team and investment professionals leverage over 400 years of accumulated investment and operational experience and bring to their portfolio companies a deep and unmatched network of value-added strategic relationships.Celesta Capital invests globally and has offices in California, Israel, India, and China
- Total investments:
- 147
- Last investment:
- Lead investor:
- 48%
Last updated:
For AI agents: llms.txt
Industries Celesta Capital invests in
Stages Celesta Capital invests in
Countries Celesta Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $3M–$50M
- Series B
- $2M–$70M
- Series C
- $2M–$130M
Investment Focus
Industry
- Software 27 (18%)
- Artificial Intelligence 23 (16%)
- Information Technology 15 (10%)
- Analytics 14 (10%)
- Machine Learning 13 (9%)
Stage
- Series B 34 (23%)
- Series A 30 (20%)
- Series C 14 (10%)
- Seed 10 (7%)
- Series D 10 (7%)
Country
- United States 58 (39%)
- India 10 (7%)
- Israel 5 (3%)
- Japan 2 (1%)
- Canada 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Michael Marks
Founding Managing Partner
|
Founding Managing Partner | Total investments: 39 | Find email | |
Anand Chandrasekaran
President, Co-founder, and Managing Partner
|
President, Co-founder, and Managing Partner | Total investments: 72 | Find email | |
Andrew Kau
Partner
|
Partner | Total investments: 9 | Find email | |
Arun Kumar
Managing Partner
|
Managing Partner | Total investments: 2 | Find email | |
Ganapathy Subramaniam
Partner
|
Partner | Total investments: 4 | Find email | |
| See all 14 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Normal Computing
|
Normal is rethinking semiconductors from the ground up.Normal EDA - Normal deploys AI software to accelerate complex hardware engineering with zero defects – all in one unified EDA platform.Normal ASICs - With the help of Normal EDA, and our closest semiconductor partners, we are building thermodynamic computing hardware that could reduce AIenergy consumption by 1000x.Normal helps enterprises deploy AI into their highest-stakes applications, where AI can reason reliably, autonomously understand its own limits. Normal’s AI application development platform is powered by a novel full-stack probabilistic machine learning infrastructure driven by thermodynamic physics. | $50M / Series B / Mar 25, 2026 | |
Movandi
|
Movandi is the fastest growing 5G mmWave solutions company with a mission to revolutionize 5G Everywhere. The company was founded by two siblings, Maryam and Reza Rofougaran, today’s top leaders in the wireless industry, whose innovations have shaped and transformed wireless in the last few decades. Having pioneered wireless systems. Movandi issolving real-world 5G mmWave deployments with unmatched differentiation and high performance core technology in 5G integrated circuits, antennas, systems, and algorithms design disciplines, to enable 5G to its full potential. Movandi’s flexible solutions solve 5G mmWave deployment cost and schedule challenges and provide future-proof solutions utilizing mesh and routing to further improve 5G coverage and capacity. Movandi’s strong and diverse system portfolio of IP and patents plays a critical role across the complete 5G ecosystem, from infrastructure to mobile, while allowing for maximum 5G coverage. | $40M / Venture - Series Unknown / Oct 14, 2025 | |
HiOctave
|
HiOctave AI solution helps small and mid' sized businesses (SMBs) automate and personalize customer experiences. | $15M / Seed / Oct 08, 2025 | |
Aurascape
|
Aurascape is a cybersecurity business that provides generative AI protection solutions against emerging cyber threats. | $50M / Series A / Apr 08, 2025 | |
Exostellar
|
Exostellar provides a platform that enables users to enhance cloud computing for greater cost efficiency by utilising its exclusive licence to patent-pending technologies created at Cornell University and combining artificial intelligence and machine learning. | $10.8M / Series A / Feb 11, 2025 | |
OneCell Diagnostics
|
OneCell Diagnostics is a Precision Oncology Liquid Biopsy Diagnostics Company. | $16M / Series A / Nov 21, 2024 | |
Crescendo
|
Crescendo developed the world’s first augmented-AI customer experience (CX) platform that combines advanced AI with a global service team to deliver outcome-driven results for fast-moving, digitally-native enterprises growing quickly. With its unique approach, Crescendo offers scalable solutions that optimize both frontline and back officeoperations, helping companies create meaningful, personalized customer experiences. | Oct 02, 2024 | |
|
Crescendo
|
Crescendo developed the world’s first augmented-AI customer experience (CX) platform that combines advanced AI with a global service team to deliver outcome-driven results for fast-moving, digitally-native enterprises growing quickly. With its unique approach, Crescendo offers scalable solutions that optimize both frontline and back officeoperations, helping companies create meaningful, personalized customer experiences. | $50M / Series C / Oct 02, 2024 | |
|
Aurascape
|
Aurascape is a cybersecurity business that provides generative AI protection solutions against emerging cyber threats. | $12.8M / Seed / Aug 06, 2024 | |
Auradine
|
Auradinescalability, sustainability and security solutions for the infrastructure, enabled by revolutionary blockchain, security, zero-knowledge and AI technologies. | $80M / Series B / Apr 10, 2024 | |
| See all 147 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Celesta Capital invest in?
Celesta Capital invests primarily in Software, Artificial Intelligence and Information Technology startups, most often at Series B and Series A stage. Most of the 147 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Celesta Capital's check size?
Celesta Capital typically joins rounds of $3M–$50M at Series A, $2M–$70M at Series B and $2M–$130M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Celesta Capital participates in.
How do I contact Celesta Capital?
Public channels for Celesta Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Celesta Capital?
The team at Celesta Capital includes Michael Marks (Founding Managing Partner), Anand Chandrasekaran (President, Co-founder, and Managing Partner) and Andrew Kau (Partner), among 14 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
